What Entyvio treats.
- Ulcerative colitis
- Crohn’s disease
The mechanism.
Entyvio (vedolizumab) is a monoclonal antibody that selectively blocks alpha-4-beta-7 integrin, preventing inflammatory immune cells from migrating specifically into the gut lining. Because Entyvio works locally in the GI tract rather than system-wide, it carries a more favorable infection-risk profile than many biologics.
Your Entyvio infusion experience.
Entyvio infusions take about 30 minutes. After three loading doses (weeks 0, 2, and 6), maintenance is every 8 weeks. Many patients notice improvement in abdominal symptoms, bowel frequency, and energy levels within the first 3 to 6 months.
Insurance & out-of-pocket cost.
Entyvio is covered by most commercial insurance and Medicare Part B when prescribed by your physician for an FDA-approved indication. We verify your benefits before your first infusion and handle prior authorization on your behalf. Most commercially insured patients pay only their standard specialty copay — typically $20–$100 per visit. Manufacturer copay assistance programs may further reduce your cost.